Targeting the NF-κB p65-MMP28 axis: Wogonoside as a novel therapeutic agent for attenuating podocyte injury in diabetic nephropathy
Top Cited Papers
Open Access
- 24 January 2025
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 138, 156406
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
This publication has 58 references indexed in Scilit:
- OmicShare tools: A zero‐code interactive online platform for biological data analysis and visualizationiMeta, 2024
- Single-cell transcriptomics reveals the ameliorative effect of rosmarinic acid on diabetic nephropathy-induced kidney injury by modulating oxidative stress and inflammationActa Pharmaceutica Sinica B, 2024
- Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospectsBiomedicine & Pharmacotherapy, 2023
- Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulationBiomedicine & Pharmacotherapy, 2023
- Role and mechanisms of the NF-ĸB signaling pathway in various developmental processesBiomedicine & Pharmacotherapy, 2022
- Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney diseaseMedicinal Research Reviews, 2022
- Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF‐κB p65Phytotherapy Research, 2021
- Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activationBiochemical Pharmacology, 2020
- Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetesDiabetologia, 2019
- NF‐kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.The EMBO Journal, 1991